Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
14.28
+0.68 (5.00%)
At close: Aug 5, 2025, 4:00 PM
14.30
+0.02 (0.14%)
After-hours: Aug 5, 2025, 7:58 PM EDT
Ligand Pharmaceuticals Analyst Ratings
Total Analysts
2
Consensus Rating
Hold
Price Target
$8.50
Upside
-40.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $3 → $10 | Strong Buy | Maintains | $3 → $10 | -29.97% | Sep 20, 2024 |
| BTIG | BTIG | Strong Sell Maintains $0.2 → $7 | Strong Sell | Maintains | $0.2 → $7 | -50.98% | Aug 23, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $32 → $12 | Strong Sell | Maintains | $32 → $12 | -15.97% | Jul 9, 2024 |
| BTIG | BTIG | Strong Sell Maintains $20 → $8 | Strong Sell | Maintains | $20 → $8 | -43.98% | Jun 26, 2024 |
| BTIG | BTIG | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | May 15, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $80 → $40 | Hold | Maintains | $80 → $40 | +180.11% | May 15, 2024 |
| William Blair | William Blair | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | May 10, 2024 |
| TD Cowen | TD Cowen | Buy Maintains $280 → $120 | Buy | Maintains | $280 → $120 | +740.34% | Mar 1, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $50 → $44 | Strong Sell | Maintains | $50 → $44 | +208.12% | Jan 23, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $50 → $44 | Strong Sell | Maintains | $50 → $44 | +208.12% | Jan 22, 2024 |
| Raymond James | Raymond James | Buy → Hold Downgrades $100 | Buy → Hold | Downgrades | $100 | +600.28% | Nov 15, 2023 |
| Raymond James | Raymond James | Buy → Hold Downgrades $100 | Buy → Hold | Downgrades | $100 | +600.28% | Nov 14, 2023 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 9, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $120 → $50 | Strong Sell | Maintains | $120 → $50 | +250.14% | Jun 5, 2023 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $120 → $50 | Hold → Strong Sell | Downgrades | $120 → $50 | +250.14% | Jun 2, 2023 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 11, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.